Skip to main content
Wellnex Life Limited logo

Wellnex Life Limited — Investor Relations & Filings

Ticker · WNX ISIN · AU0000162281 LEI · 2138001FL9C36DUOUX55 ASX Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2026-04-30 Business and Financial …
Country AU Australia
Listing ASX WNX

About Wellnex Life Limited

https://wellnexlife.com.au/

Wellnex Life Limited is a consumer healthcare company that develops, markets, and distributes a portfolio of health and wellness products. The company focuses on creating and acquiring brands that offer solutions for everyday consumer needs. Its key product categories include topical pain relief, energy supplements, sleep aids, and oral care. The brand portfolio features Pain Away, a topical analgesic for muscle and joint pain; Wakey Wakey, a line of energy and multivitamin supplements; Nighty Night, a sleep aid formulated with Ashwagandha and Magnesium; and Mr. Bright, a range of teeth whitening products. The company's mission is to innovate and deliver high-quality health and wellness solutions to consumers.

Recent filings

Filing Released Lang Actions
Q3 FY26 Quarterly Update and Appendix 4C
Business and Financial Review
2026-04-30 English
Extension of Loan Repayment
Capital/Financing Update Classification · 1% confidence The document is an ASX/AIM/RNS announcement detailing an extension to repayment terms of loans to former directors, including changes to loan principal, interest accrual, and repayment dates. It constitutes an update on the company's financing arrangements and capital structure. This fits the definition of a Capital/Financing Update rather than a dividend, share issue, management change, or regulatory filing fallback.
2026-04-23 English
Extension of Loan Repayment 2 pages 145.6KB
Capital/Financing Update Classification · 1% confidence The document is a corporate announcement on ASX/AIM regarding an extension of loan repayment terms and associated interest/principal adjustments to former directors. This is specifically an update on the company’s financing arrangements rather than a dividend notice, management change, or report publication. Therefore, it fits the Capital/Financing Update category.
2026-04-22 English
Update on Loan Repayment 1 page 130.0KB
Capital/Financing Update Classification · 1% confidence The document is a short ASX/AIM announcement updating investors on the status of loan repayments (including an extension of repayment deadlines) owed by former directors. This falls squarely under financing activities and changes to the company’s capital structure rather than a full financial report or regulatory fallback. Therefore, it should be classified as a Capital/Financing Update (CAP).
2026-04-21 English
Update on loan repayment
Capital/Financing Update Classification · 1% confidence The document is an RNS ASX/AIM announcement titled “Update on loan repayment” detailing the company’s discussions on extending repayment deadlines for loans (capital structure/financing activity). This is not an earnings release, interim report, or board change notice, but specifically an update on financing/loans. Under the definitions, this falls squarely under Capital/Financing Update (CAP).
2026-04-21 English
Notification of cessation of securities - WNX 4 pages 14.7KB
Regulatory Filings
2026-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.